Trending Down-0.0800 (-8.1633%)
  • Bid / Lots
    0.8900/ 9
  • Ask / Lots
    0.9000/ 45
  • Open / Previous Close
    0.9100 / 0.9800
  • Day Range
    Low 0.8400
    High 0.9501
  • 52 Week Range
    Low 0.6490
    High 6.9800
  • Volume
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.98
09:32 ET75180.8957
09:33 ET149140.8905
09:35 ET116760.8571
09:37 ET200690.85
09:39 ET147240.85
09:42 ET49160.8499
09:44 ET152740.84
09:46 ET364170.9235
09:48 ET1000.88175
09:50 ET5500.87
09:51 ET122450.87015
09:53 ET11570.875
09:55 ET6150.870001
09:57 ET80450.885
10:00 ET5000.9075
10:02 ET3000.91
10:06 ET1000.91
10:08 ET142320.87
10:09 ET8370.89
10:11 ET24840.89
10:13 ET25670.89
10:15 ET8070.9
10:18 ET1010.8901
10:20 ET122970.88
10:22 ET107500.91
10:24 ET3000.8801
10:26 ET7000.901247
10:38 ET1200.8956
10:40 ET38150.91
10:42 ET106470.91
10:47 ET1000.8956
10:49 ET11000.8957
10:51 ET3000.9
10:54 ET7220.9
11:03 ET5000.91
11:12 ET5420.9098
11:16 ET31390.91
11:18 ET4950.91
11:20 ET4000.900101
11:23 ET12920.91
11:25 ET207480.95
11:38 ET34400.95
11:39 ET191520.95
11:41 ET4710.95
11:50 ET4030.925
11:57 ET14000.925
11:59 ET1180.905375
12:03 ET31110.91005
12:10 ET2500.910595
12:14 ET10000.91
12:21 ET18000.9
12:28 ET22280.91
12:35 ET16500.9099
12:42 ET13190.9002
12:48 ET15880.9
12:57 ET23000.9001
01:00 ET44110.8901
01:02 ET37690.89
01:20 ET7880.9
01:27 ET10000.9
01:31 ET5000.9099
01:36 ET21460.9
01:38 ET1000.9
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesENVB
Enveric Biosciences Inc
United StatesELOX
Eloxx Pharmaceuticals Inc
United StatesHSTC
HST Global Inc
United StatesCWBR
CohBar Inc
United StatesQNRX
Quoin Pharmaceuticals Ltd
United StatesQRON
Qrons Inc
As of 2024-02-26

Company Information

Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders. The Company through Psybrary has created a robust intellectual property (IP) portfolio of New Chemical Entities (NCEs) for specific mental health indications or physical ailments. The Company's lead program, EB-373, is a next-generation prodrug of psilocin, the active metabolite of psilocybin. EB-373 is a drug candidate from the EVM201 Series advancing through preclinical development for the treatment of anxiety disorders. The Company is also advancing its third generation of therapeutics, the EVM301 Series, that eliminates the psychedelic experience and removes unwanted effects, reducing safety concerns, and hence offering a novel and holistic approach for treating central nervous system disorders.

Contact Information

4851 Tamiami Trail N, Suite 200NAPLES, FL, United States 34103


Non-Executive Independent Chairman of the Board
Mike Webb
Chief Executive Officer, Director
Joseph Tucker
Chief Financial Officer
Kevin Coveney
Chief Innovation Officer
Peter Facchini
Independent Director
George Kegler

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
Revenue (TTM)
Shares Outstanding
Dividend Yield
Annual Dividend Rate
Ex-Dividend Date
Pay Date
Book Value
P/E Ratio
Price/Sales (TTM)
Price/Cash Flow (TTM)
Operating Margin
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.